What is Pearlii?
Pearlii operates at the intersection of dental health and software-as-a-service, providing a comprehensive platform designed to optimize dental health management. Based in Australia, the firm utilizes sophisticated diagnostic tools and data-driven insights to bridge the gap between patients and dental care providers. By digitizing traditional dental workflows, Pearlii addresses critical inefficiencies in the industry, positioning itself as a vital infrastructure provider for modern dental practices. Its market position is defined by a commitment to accessible, technology-enabled oral health solutions that cater to both individual consumers and enterprise-level clinical operations.
How much funding has Pearlii raised?
Pearlii has raised a total of $2.8M across 2 funding rounds:
Angel/Seed
$1.3M
Other Financing Round
$1.5M
Angel/Seed (2020): $1.3M with participation from Roger Allen and Justin Lieberman
Other Financing Round (2022): $1.5M led by BRC Capital
Key Investors in Pearlii
BRC Capital
BRC Capital is a private equity and venture capital firm based in Beverly Hills, California, known for its focus on scaling high-potential enterprises.
Roger Allen
An experienced angel investor providing early-stage capital and strategic guidance to emerging technology ventures.
Justin Lieberman
A private investor focused on supporting innovative startups within the health and technology sectors.
What's next for Pearlii?
With the successful closure of this major strategic investment, Pearlii is well-positioned to accelerate its product development roadmap and expand its footprint in the competitive healthtech market. The capital will likely be deployed to enhance the platform's diagnostic capabilities and scale operations to meet the growing demand for digital dental health management. As the company moves into this next phase of growth, the focus will shift toward deepening its enterprise integrations and solidifying its presence as a leader in the dental technology space. Investors will be monitoring the firm's ability to maintain its growth trajectory while navigating the complexities of international health regulations and clinical adoption cycles.
See full Pearlii company page
